Sugar acids and derivatives
BIOHIPPO T-bet-TAL-BSD LV
T-bet-TAL-BSD is a transcription factor reporter lentiviral vector designed to monitor the target signaling pathway in living cells The construct carries a fluorescent reporter gene under the control of pathway responsive elements and includes a blasticidin selection marker to generate stable cell pools The lentivirus is provided as a ready to use VSV G pseudotyped preparation for efficient gene delivery and stable genomic integration Each vial provides a nominal titer of 5x10E6 transducing units TU Typical applications include pathway activation studies assay development compound screening and mechanism of action research The system is suitable for human and mouse cells and can be read using standard fluorescence microscopy flow cytometry or luciferase assays depending on the reporter gene This product is intended for research use only and is not for diagnostic or therapeutic procedures
Medchemexpress LLC Antitumor agent-127 | 99.1% | 1670.92 | C86H107N15O18S | 10 MG
Antitumor agent-127 is a macrocyclic peptide ROR1 ligand supplied for research use. It shows nanomolar cellular binding and internalization in tumor cell lines, and is provided with supporting analytical documentation for characterization.
Ambeed 2R 3R 4S 5S 6S 2Bromo6 methox
(2R,3R,4S,5S,6S)-2-Bromo-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate, 21085-72-3, 97%
AdipoGen C9-L-HSL
Chemical. CAS 177158-21-3. Formula C13H23NO3. MW 241.33. N-Nonanoyl-L-homoserine lactone is a small diffusible signaling molecule involved in quorum sensing, controlling gene expression and affecting cellular metabolism. The diverse applications of this kind of molecule include regulation of virulence in general, infection prevention, and formation of biofilms.
Medchemexpress LLC D-Moses (D-45) | 2084850-77-9 | >98.0% | 360.46 g/mol | C21H24N6 | 10 MG
D-Moses (D-45) is the D-enantiomer of L-Moses and is provided as an inactive control compound for studies of the p300/CBP-associated factor (PCAF) bromodomain. It is intended for research use and is supplied as a powder with reported high purity for biochemical and cellular assays (CAS 2084850-77-9).
- Inactive enantiomer control for bromodomain assays.
- Suitable for biochemical and cell-based experiments.
- Reported purity greater than 98%.
- Available in small, precise milligram sizes for screening.
- Powder form with limited aqueous solubility; soluble in common organic solvents.
Medchemexpress LLC Bet-bay 002 | 1588521-78-1 | 99.8% | 403.86 g/mol | C22H18ClN5O | 100MG
BET-BAY 002 is a small-molecule BET bromodomain inhibitor intended for research use. It demonstrates activity in multiple myeloma models and is provided as a high-purity solid for in vitro and preclinical studies. The compound is soluble in DMSO and is offered in multiple pack sizes to support assay development and screening.
- Potent BET bromodomain inhibitor with reported efficacy in multiple myeloma models.
- High purity (99.8%) suitable for biological assays.
- Soluble in DMSO for convenient reconstitution.
- Available in multiple quantities including a 100 mg package.
- Molecular weight 403.86 g/mol and formula C22H18ClN5O.